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Abstract
In the United States, 79 million people are currently infected with Human Papilloma
Virus (HPV) and it is estimated that an additional 14 to 20 million people will be infected
with HPV every year. Infection with HPV increased to 52.7 % of preventable infections
within the United States in 2012, and 39.6% of the infected population are adolescents
engaged in sexual activities. The practice-focused question that this project addressed
was: To what extent can an educational program influence the HPV vaccination rate in a
small family practice clinic located in Texas? The main purpose of this project was to
increase education within the clinic community using a quality improvement approach
and guided by Healthy People Goals 2020. Barriers to HPV vaccination were validated
through focus group discussion held with clinic staff. Parental resistance was due to a
misconception that the vaccine would lead to sexual promiscuity in the adolescent
population, and that a single dose is adequate protection. A bilingual educational session
was held with 15 clinic staff members with the purpose of enhancing knowledge,
influencing parental attitudes and beliefs, providing patient educational tools, and thereby
increasing vaccination acceptance by 37.8% within an underserved and vulnerable
population. The results of the focus group and educational sessions were presented to an
expert panel made up of five community leaders and the senior clinic leader who
approved the approach and suggested additional ways to promote HPV vaccination.
Clinic leadership agreed to adjust policy mandating use of the educational materials with
clinic patients. Positive social change will result from the integration of this educational
approach into clinic practice by increasing vaccination acceptance.
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Section 1: Nature of the Project
Introduction
Multiple factors may interfere in the well-being and adequate development of
children and adolescents. One of the most common factors is known as sexually
transmitted infection (STI) due to unprotected sexual relations. Human Papilloma Virus
(HPV) causes the most frequent STIs that have been reported among adolescents and
young adults from the United States (Centers for Disease Control and Prevention [CDC],
2013a). In the United States, 79 million people are currently infected with HPV and it is
estimated that an additional 14-20 million people will be infected with HPV every year
(Bethesda, 2014).
According to the CDC (2013b), HPV Types 16 and 18 are responsible for 79% of
anogenital carcinomas, 66% of cervical carcinomas, and 62% of oropharyngeal cancer.
The American Cancer Society (2015) estimated that around 12,900 new cases of cervical
cancer and over 4,100 deaths will occur in the United States in 2015; Bethesda (2014)
urged President Obama to coordinate with National Health Minister and create new
strategies to increase HPV vaccination intake as a crucial tool to prevent HPV infection.
The CDC (2013c) reported that 35% of adolescent girls and 14 % of teenage boys
completed all three doses in 2010. These statistics constitute one of the lowest rates of
HPV vaccination in the previous 5 years as per (CDC, 2013d). The CDC (2013d) is
engaged along with Healthy People 2020 to provide immunization for preventable
diseases. The costs associated with HPV treatment are estimated to be as high as $18.2
billion for 2017 (Bethesda, 2014). Powell et al. (2012) pointed out that HPV constitutes

2
the most frequent STI diagnosed, is expensive to treat, and is difficult to manage in new
patients who acquired t. Reliable strategies to improve the HPV vaccination rates are
needed in primary care settings.
Problem Statement
The problem addressed in this project is that there is a very low HPV
immunization rate among vulnerable female and male adolescents aged 9-17 years old
who qualify for HPV vaccination, and who seek treatment at the Family Health clinic.
The HPV vaccination prevents further HPV infection and its consequences. The chosen
metropolitan clinic in Houston serves a population of 21,209 patients, and 22.6 % of
these adolescents are high risk of being infected by HPV. Most of the population are
Hispanic, African American, and Middle Eastern with a low-income status, and Medicaid
as main health insurance coverage.
The HPV vaccination rate in this clinic was 9.4 % in 2015, then dropped to 6.7 %
in 2016, which is considerably lower than the recommended Healthy People 2020 goal of
80%. Pitts and Adams (2013) reported that HPV vaccination rates are dropping to the
lowest point since 2010. Hopkins and Wood (2013) explained that HPV infection has
reached up to 52.7 % of preventable infections within the United States in 2012. Bartlett
and Peterson (2012) determined that 39.6% of the infected population are adolescents
engaged in unprotected sexual activities.
HPV vaccination is an FDA-approved vaccine that protects against HPV upon
completing three-dose series (Hopkins & Woods, 2013). Multiple factors may interfere
with HPV the vaccination process. Bartlett and Peterson (2013) described a strong link
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between parental resistance and incomplete vaccination among adolescents studied.
Parental hesitancy, language barriers, lack of healthcare coverage, undocumented
families fearful to be deported, a deficit of knowledge on treatment, and poor risk
perception of HPV infection are common challenges to overcome within the targeted
population. Another issue that interferes with HPV vaccination adherence is the lack of
knowledge among healthcare providers and nurses regarding HPV prevention (Reiter et
al., 2011). Perkins and Clark (2013) pointed out that proper education and good
communication between providers, parents and patients may change one’s perception
regarding HPV vaccination. The lack of knowledge about HPV immunization in
providers may interfere with accurate documentation in chart records, which creates a
gap in immunization registries, another practice gap. ImmTrac is the name of the
proprietary immunization registry used in Texas and sponsored by the Texas Department
of Health. The engagement of professionals in the HPV vaccination educational project
and its documentation throughout ImmTrac will have significance for the practice of
nursing, and provide a higher quality of service given to the patients targeted by this
project.
Purpose Statement
The purpose of this project is to increase acceptance of HPV vaccination within
the targeted clinic population while improving practice regarding HPV vaccination at the
project site. This will enhance the effectiveness and strength of protocols, health
promotion activities, and disease prevention tools as part of primary care goals. Per the
Department of Health and Human Services, (DHSS) (2013), one of the goals of Healthy
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People 2020 is to increase vaccination coverage up to 80% and to provide adequate and
current information on the benefits of vaccination. The present project was developed
following a Quality Improvement (QI) model, as this is consistent with the needs of the
clinic and included in the clinic’s QI plan.
Validating barriers to HPV vaccination with clinic staff is a critical component of
the project, as well as providing an educational solution with the intent of improving
HPV vaccination rates among the clinic’s teenage population. An expert panel comprised
of community leaders and clinic executive leadership was also employed to further the
project goals. The CDC (2013) encouraged nurses and healthcare providers to promote
HPV vaccination vaccine and to educate the community on its benefits to prevent HPV
infection and further consequences. Bartlett and Peterson (2012) described a significant
increase in HPV vaccine rates after intervention in which providers recommended HPV
vaccination before beginning of sexual intercourse.
The DHSS (2013) reported that it is the responsibility of healthcare providers to
monitor HPV vaccination and track HPV three dosage rate accurately. The metropolitan
southwest clinic in Houston, which is the focus of this DNP QI project, seeks to properly
track adolescents who complete three-dosage series and assure an accurate report in
Texas Immunization Registry (ImmTrac). Perkins and Clark (2013) asserted that
providers did not accurately report 36.6% of patients’ HPV vaccinations within ImmTrac
which creates a gap that leads to inaccurate reports and economic loss within the
healthcare industry. One factor contributing to an inaccurate Immtrac report is related to
lack of knowledge of HPV vaccination and poor communication between providers and
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nurses (DHSS, 2013). This QI project aims to validate barriers to HPV vaccination,
increase awareness of the consequences of a low rate of HPV vaccination, and implement
strategies to improve education in both the Spanish and English-speaking population.
The primary objective of this project is to increase HPV vaccination rates in
adolescents by educating parents on the benefits of obtaining vaccine against HPV in
their daughters and sons. The main goals of this project are aimed at enhancing the
acceptance of the HPV vaccination within the selected community, thereby increasing
HPV vaccination and three-dose regimen.
Nature of the Doctoral Project
The nature of this doctoral project is centered on changing the attitudes toward
vaccination and gaining more acceptance among parents and adolescents. The CDC
(2013e) reported a marked 15% decrease of HPV vaccination during 2012. This is
concerning given the fact that about 25% of adolescents engage in sexual relationships in
the United States (Bartlett & Peterson, 2013). Healthcare providers usually recommend
that the three-series HPV vaccination should be completed before becoming sexually
active (Leask et al., 2012).
The present pattern of low HPV vaccination rates leads to multiple problems,
such as reduced HPV coverage among adolescents (Bartlett & Peterson, 2012), loss of
millions of dollars by funding a vaccine with a little acceptance (Pitts & Adams, 2013),
and higher risk of being infected by HPV, leading to the development of further
anogenital and/or oropharyngeal cancers (Hopkins & Wood, 2013). The DHSS (2013)
asserted that the financial cost of providing HPV vaccine would be around $16.4 billion.
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Because most adolescents in the project population belong to a low-income community
and are enrolled in Medicaid, uninsured or underinsured children and adolescents are
covered by the federal Vaccines for Children (VFC) program without any cost to their
parents.
The DNP QI project consists of the following four elements: (a) a focus group
discussion among staff members, to identify knowledge deficits and their perceptions of
parentally held-myths and misconceptions about HPV vaccination, (b) development of
patient education materials produced in English and Spanish, which will assist health care
providers in their support of parents, (c) an educational session that will heighten
awareness and dispel myths surrounding the HPV vaccination and (d) a presentation of
the project and project materials to the clinic and community leaders at the Houston site
to secure their approval for full implementation of the project and disseminate the
education to the broader community. It is also the goal of this DNP QI project to
positively influence the HPV vaccination rate at the project site. However, this outcome
may occur outside of the scope of the DNP project timeline. Regardless, the project will
include formative and summative evaluation strategies on the five components listed
above.
Significance of the DNP Project
This DNP project provided educational tools and materials to enhance the
knowledge of HPV prevention among adolescents and young adults after an analysis of
barriers which interfere with HPV vaccination. The project aligns with ANCC DNP’s
Essential VII, which focuses on clinical prevention and population health to improve the
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nation’s health. This DNP project aligns with pediatric guidelines and Texas Department
of State Heath Service throughout Immunization Unit by providing material to parents
and families which supported the well-being and healthy growth of children and
adolescents. Other sources of evidence were sought from CINAHL, the Walden
University Library, OVID, and PubMed databases (Appendix A).
By involving clinic staff members and key community leaders, the project
provided an additional solution to promote greater HPV vaccination and prevent the
sequelae associated with HPV infection. Texas is a state with one of the highest rates of
cervical cancer mortality in the country, but with the lowest rate of HPV vaccination.
According to Pitts and Adams (2013), the vaccines for children are federally funded
through programs that support eligible children (Medicaid, the uninsured, Native
American or Alaskan Native, and refugee). However, there is a gap with HPV
vaccination administration since it is not mandated by U.S immunization program. The
CDC (2013) pointed out state legislatures throughout the U.S. have considered if
adolescents are required to receive the HPV vaccination for school entry. Former Texas
Governor Perry proposed a state law to administer the HPV vaccine for adolescents upon
entry into middle school as well, yet the state legislature did not pass the bill. The project
objective is to provide the best information about HPV vaccination by providers and
nurses, to decrease language barriers and to reduce myths about HPV, and
miscommunication between parents and teens. Graham and Mishra (2011) explained that
in most low-income countries, the inclusion of the HPV vaccine into national vaccination
programs had not been easily implemented due financial constraints, lack of
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infrastructure, health priorities, and providers’ minimal interest in participating in such
program. In the absence of a legal mandate, physician and health care provider
recommendations for HPV vaccination may influence parents’ and adolescents’ decisions
regarding vaccination (Graham & Mishra, 2011) resulting in significant social change for
the clinic community. Another significance will be updating HPV vaccination policy
proposal, therefore enhancing education level and immunization acceptance.
Summary
The DHSS (2013) described the average cost of the HPV vaccine as $130 to $152
per dose and missing one of the three require dosages will create a loss of $260- $344
million dollars annually. The project was implemented at a Family and Pediatric Clinic
from Southwest area of Houston, TX, an organization that serves a population of 2,209
patients, with a 22.6 % of these patients, adolescents and young adults. Most of the
population are Hispanics, African Americans, and Arabic with a low socio-economic
status. The project population included adolescents (male and female) between 9-18 years
old who have not received the HPV vaccination or who have not completed the three
dosages as required. There is only a 6.2 % of total adolescents that completed the three
dosages as ordered at the Metropolitan clinic in the southwest of Houston, Texas.
The relevance of this DNP QI study is that the project engaged the stakeholders,
including national organizations such as AANP, community leaders, healthcare workers,
and parents. By involving community leaders, it created an opportunity to propose new
strategies in finding ways to promote the HPV vaccinations in the project’s population.
Through the work of a project team involving these key stakeholders, an educational
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solution was developed and implemented, including an educational intervention aimed at
decreasing parental hesitancy and miscommunication, while at the same time
encouraging providers and nurses to track and report patients’ within ImmTrac system
correctly.
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Section 2: Background and Context
Introduction
While there are 79 million people currently infected with HPV, more than 14
million people are expected to be infected with HPV every year in the United States
(Bethesda, 2014). The purpose of this study was to increase education within a Houston
community selected based on the need for quality improvement related to the Healthy
People Goals 2020. This section includes a review of key concepts, models and theories
utilized in this project and the project’s relevance to nursing practice, as well as
information regarding the local venue and context for the project.
Concepts, Models and Theories
HPV Infection and Vaccination
HPV is a virus with more than 150 subtypes identified, including nearly 40 that
may directly infect the genitals. There are a few high-risk types such as Types 16 and 18,
which may produce cervical cell abnormalities, and these types are precursors to oral and
genital carcinomas (CDC, 2013). The CDC (2013) explained that a vaccine is a
biological preparation designed to improve the immune system for an illness. DHSS
(2013) explained that a vaccine typically contains an agent that may resemble a disease
and stimulates the body's immune system to recognize the agent and destroy it, but
creates a memory to attack and fight microorganism to prevent any further illness. There
are two primary HPV vaccines, the bivalent HPV vaccine (HPV2) and quadrivalent HPV
vaccine (HPV4), both licensed for use in the United States. These vaccines are
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administered in three dosages to protect against HPV Types 16 and 18, which are
responsible for producing nearly 70% of cervical carcinomas (CDC, 2013).
The National Childhood Vaccine Act signed into law in 1986, requires that any
minor needs guardian or legal representative consent to receive the vaccination. The legal
representative will be defined as a parent or an individual who qualifies as a legal
guardian under state law (Department of Health & Human Services, 2013).
Visual presentations or oral explanations in English and Spanish to assure proper
knowledge of HPV immunization benefits are the types of HPV vaccination education
that can influence a change in behavior. Parental education in this DNP project includes
pre-post intervention questionnaire on HPV prevention in the hope to promote HPV
vaccination compliance in adolescents.
Definitions of Terms
Prevalence: The number of real subjects with a determined disease or health
condition within a population at the specific time (Kettner, Moroney, & Martin, 2017, p.
62).
ImmTract: Software that constitutes the main Texas Immunization Registry,
offered by the Texas Department of State Health Services (DSHS) at no cost. ImmTrac
consolidates and stores immunization records from multiple sources electronically within
the centralized system (Department of Health & Human Services,2013).
Low income community: It is defined by estimated earnings of $18,660 for a
family of four (two adults, two children), which it is based on three times the estimate of
a low-income family’s food budget, assuming that the other two-thirds can be spent on
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clothing, houses, clothing, and other primary needs. (Department of Health & Human
Services, 2013).
Preventive medicine: A medical science derived from a combination of
biostatistics, epidemiology, health services management, control and prevention of
environmental, and clinical medicine activities such as healthcare promotion supported
by the assessment of cultural, social and behavioral influences on health (American
Board of Preventive Medicine, 2016).
Barriers to HPV Vaccination (Parents and Providers)
According to Bethesda (2014), the main barrier that influences HPV vaccination
is the lack of knowledge and misconceptions among parents about the timing of the
vaccine and sexual behavior among adolescents. Pitts and Adams (2013) pointed out that
low perceived risk of HPV infection, lack of provider recommendations, and concerns on
vaccination cost were also identified as potential HPV vaccination barriers. Pitts and
Adams showed throughout a descriptive study among two different groups (n= 60 and
184, respectively) that health care professionals either offered little information about the
vaccine, or failed to recommend it. Finally, within low socioeconomic status
communities, uninsured, ethnic minority, and immigrant women (N = 490) it was found
that the main barriers were related to finding a clinic that offered the vaccine or lack of
insurance coverage (Holman et al., 2014).
According to McCabe (2014) a random sample study of 2766 parents of 9–10year-old children were identiﬁed by Medicaid and Children’s Health Insurance Program
(CHIP) insurance database and parents were invited to participate in a pilot study by
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answering a questionnaire. McCabe implemented a mixed statistical method, and used
chi-square and independent-sample t-tests to identify barriers for HPV vaccination. There
was a 69 % demonstrated lack of knowledge regarding HPV benefits, but 72 % showed
poor perception of HPV risk among their sons and daughters.
Interventions That are Effective
The effectiveness of interventions was supported by increasing HPV vaccine rate
among adolescents, and parental acceptance to initiate and complete three dosages.
Empowering community leaders and teachers to be vaccine champions within a
community with the goal of disseminating information about HPV vaccine benefits is
also beneficial. (Holman et al., 2014). Per Malo et al. (2013), a group of parents surveyed
(N=273) reported a belief that only sexually active adolescents are required to have the
vaccine; therefore, 78% will decline HPV vaccination if they are not adequately
instructed on such treatment. Smulian, Mitchell, and Stokley (2016) asserted that another
effective intervention may be implementing a reminder and recall method that will notify
parents when child is due to start the HPV vaccine series or complete the second or third
dose per U.S immunization protocol. Dorell, Yankey, and Strasser (2011) conducted
multiple surveys of Hispanic adolescents (n =77) and parents of adolescents (n=202) and
focus groups with parents of 11- to 18-year-olds. The surveys were conducted to evaluate
knowledge, and attitudes related to HPV vaccination acceptance. The results encouraged
the authors to develop a bilingual written brochure for community members. It was
reported that 92% of healthcare providers are seen by the public as a trusted source of
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health information, and that on their advice they may vaccinate their daughters and sons
if it is recommended.
Ylitalo, Lee, and Mehta (2013) utilized the focus groups as an approach method
and intervention to enhance HPV vaccination acceptance. The focus group helped to
determine the level of vaccination information that is accessible in their respective
languages. Polit (2010) indicated that providing adequate, clear, and accessible
information to parents can reduce concerns and misperceptions about vaccines.
Models and Theories
Leininger's transcultural care theory was chosen to provide a strong and
appropriate foundation for addressing the identified project problem (Bodenheimer &
Grumbach (2016). Bodenheimer and Grumbach (2016) described that this theory was
used to develop educational tools throughout educative interventions within a
multicultural and diverse community and aims to enhance knowledge regarding HPV
vaccination immunization to prevent miscommunication between providers and parents
and adolescents. Hopkins and Wood (2013) asserted that the most common factors that
affect vaccination engagement and healthcare promotion activities are language barriers
and poor education. The importance of using this theory is supported by the fact that it
will assist providers and healthcare staffs in identifying the varying beliefs and thoughts
from multicultural populations (Kettner, Moroney, & Martin, 2017).
The health promotion nursing model, as described by Pender (1982) was used to
strengthen further intervention within the targeted population. This model is an
appropriate choice to enhance HPV vaccination intake and benefits of immunization
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within the described population. Im and Ju Chang (2012) explained that the health
promotion model is a design model to assure a higher quality of health promotion in
primary care settings. This model also focused on the interaction between patients and the
environment, which helps providers and nurses determine lifestyle and healthcare
perceptions. The health promotion model fits this DNP QI project since the main goal
will be change of attitude and risk perception regarding HPV immunization.
Local Background and Context
There is marked decreased rate of HPV vaccination when comparing 2015 to
2016, as shown in Table 1. Another issue is that females are the ones who mostly receive
the vaccine. A larger majority of women (72.7%) received HPV vaccination vaccine at a
metropolitan Family Clinic during 2016; meanwhile, just 27.2% of males were brought to
the office and accepted immunization treatment. In the observation of the DNP project
leader, most of the parents refused to vaccinate their sons because they believed that
males are not at risk of acquiring HPV infection. Another fact is that most parents
received information from the school and Internet; yet, there was not enough
understanding of the HPV prevention, and most of them believed that sexually active
adolescents were not at risk. According to the CDC (2013e), HPV vaccination vaccine
should be administrated before sexual debut to increase effectiveness and protection.
Information for Table 1 came from ImmTrac and patient medical records, December
2016.
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Table 1
HPV Series Completion Among Adolescents 9-17 Years of Age
January, 2015December,
2015

January, 2016December, 2016

Place

Total of
Records

Completed
Three Doses

Rate

Total of Records

Completed
Three Doses

Rate

Metro City

826,674

77, 432

9.4%

798,845

54,597

6.7%

Childrens’
(Hospital)

53,989

4,247

7.9%

50, 612

2,803

5.5%

Family
(Clinic)

176

23

13.1%

121

11

9.1%

Gender and demographics are other facets in determining the vaccination rate.
Tables 2 and 3 show data for vaccinations by gender and by demographic accordingly.
Table 2
HPV Dose Series Vaccination Among Adolescents Per Gender at Family Clinic
January, 2015December, 2015

January, 2016December,
2016

Total Number of
Adolescents

Rate

Total Number
of Adolescents

Rate

Male

68

38.7%

33

27.3%

Female

106

61.3%

88

72.7%

Total

176

100%

121

100%
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Table 3
HPV Dose Series Vaccinations Among Adolescents Per Demographic
January,
2015December,
2015

January, 206December,
2016

Total of
Adolescents

Rate

Total of
Adolescents

Rate

African American

85

48.3%

62

51.2%

Caucasian

39

22.1%

28

23.1%

Hispanic/Latino

28

15.9%

14

11.6%

Asian

24

13.7%

17

14.1%

Total

176

100%

121

100%

The Hispanic population exhibited the lowest prevalence of HPV vaccination
administration. Most of Hispanics and Latino parents showed a low HPV vaccine
knowledge due to the poor education secondary language barrier as one of the
fundamental causes of vaccine acceptance (Pitts& Adams, 2013). Adequate
recommendations in Spanish may enhance Hispanic parents’ perceptions about the
importance of HPV vaccination vaccine to prevent HPV infection (Kepka, Ulrich, &
Coronado, 2012). Another factor that places Hispanics as a higher vulnerable population
is the illegal immigration and lack of healthcare coverage, which made them return to
their native country and miss subsequent HPV vaccination doses.
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Role of the DNP Student
I will serve as project leader, to conduct the focus groups with staff and with
community leaders, develop the patient education materials in English and Spanish,
implement the educational solution with staff members and seek approvals for the project
from the senior administrative team at the clinic through the QI program at the site. As
this project is part of an overreaching QI initiative, the impact on the actual HPV
vaccination rate may not be apparent for several months after the conclusion of the focus
groups and educational plan. This notwithstanding, as project leader, a formative and
summative evaluation plan will be developed and carried out.
The positive change of this proposed research problem will be reevaluating and
assessing protocols and tools that are not useful incentives to patients encouraging them
to complete HPV vaccination immunization. Another positive change is decreasing HPV
infection prevalence among adolescents and the anogenital and pharyngeal cancer risk.
These changes will be supported by enhancing education and increasing community
engagement for completing the three-dose series as per immunization guidelines. Most of
the literature reviewed pointed out the benefits of mass HPV immunization or community
health fairs that focus on the importance of HPV vaccination in HPV prevention as part
of this positive social change and community impact.
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Section 3: Collection and Analysis of Evidence
Introduction
This DNP QI Project was developed with the main purpose of changing attitudes
and enhancing HPV vaccine acceptance, thereby increasing the HPV vaccination rate.
Researchers have pointed out the importance of administering the HPV vaccination
between the ages of 9-17 years old (ACOG, 2012). According to Pitts and Adams (2013),
the HPV vaccination should be administered before the beginning of sexual relationships
in order to achieve higher effectiveness. The American College of Obstetricians and
Gynecologists (2012) reported that 14% of patients completed the three-dose series in
2010. Hopkins and Wood (2013) reported that 355,000 new cases of anogenital warts
were produced by HPV infection.
The selected issue has multiple facets, such as reduced HPV coverage among
adolescents (Bartlett & Peterson, 2012), the loss of millions of dollars by funding a
vaccine with little acceptance (Pitts & Adams, 2013), and higher risk of being infected by
HPV, along with the development of further anogenital and/or oropharyngeal cancers
(Hopkins & Wood, 2013). I identified vaccine knowledge deficit and poor risk perception
within the targeted population as significant gaps that need to be addressed. Most parents
believe that their daughters and sons do not need to complete three-dose series and that,
missing a dose will not compromise immunization status (McCabe,2014).
Practice-Focused Question
This DNP QI project proposal took place in an outpatient family practice clinic,
localized within the urban area of a Texas metropolitan area. Outcomes were measured
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based on project questions formatively through initiating stakeholder meetings, gathering
and ranking evidence, and revising HPV vaccination policies. Outcomes were measured
summatively, through stakeholder satisfaction with DNP project leadership survey and a
finalized HPV vaccination policy, finalized healthcare professional HPV education
module, finalized patient HPV education brochure and a pre-post implementation
outcome measurement strategy (including HPV three-dose vaccination completion rate).
Responding to this issue, the scholarly project question was: Can educational tools
designed in English and Spanish increase HPV immunization rate among adolescents,
and engage them to complete the three-dosage requirement for the HPV vaccination?
The PICOT question format was used to address the selected problem and
outcomes desired
P: The population targeted is female and male adolescents (9-17 years old) and
their parents.
I: The proposed plan of action and intervention was an educational package
(Spanish-English) regarding HPV disease prevention and HPV vaccine’s benefits
throughout an updated immunization policy proposal.
C: Educational sessions were conducted with focus groups and leadership expert
panel
O: The desired outcome will be increasing HPV vaccination acceptance by
enhancing knowledge among parents and caregivers.
T: The time interval to develop the DNP project was 3 to 6 months (divided in
two-quarters)
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Sources of Evidence
Literature Review
An important source of evidence supporting this project is a thorough and
comprehensive review of the literature, presented in this proposal in section 2 and
throughout the document. To secure adequate depth in this review, valid databases were
searched by using key terms such as HPV vaccination vaccine, immunization issues,
vaccination in adolescents, parental consent problems, Human Papillomavirus (HPV),
and ethical and legal topics of an HPV vaccine. There was a total of 679 articles fewer
than 5 years old relating to the selected topic. Each article that met the criteria with robust
evidence based-practice discussion and strong statistic results and high relevance was
included in the literature review and presented in Section 2. I identified 382 qualitative
studies, 237 quantitative studies, and 60 mixed studies methods. Most of the studies
showed inclusion criteria a consent to participate, parents, and adolescents willing to
cooperate with studies and completion of the three HPV dosages. The studies chosen
represented a higher and valid sources due statistic methods, solid results and accuracy of
discussion and strategies provided. Other sources of evidence were sought from
Cumulative Index to Nursing and Allied Health Literature (CINAHL), Walden
University library center, OVID, and PubMed databases.
Additional Evidence Supporting the Project
Focus groups were held with staff members and community leaders and shed
additional light on the barriers that prevent effective HPV vaccination. The qualitative
data from these proposed focus groups were summarized and presented to the senior
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leaders at the site, validating the need for an educational solution. The primary aim of
this DNP project was to provide educational tools and materials to enhance knowledge of
HPV prevention among adolescents and young adults. Assessment-intervention based on
the Advisory Committee on Immunization Practices (ACIP) guidelines will focus goals
and outcomes by comparing HPV vaccination vaccine rate pre-and post-intervention after
the DNP project is completed. This project aligns with ANCC DNP’s Essential VII,
which is focused on clinical prevention and population health to improve nation’s health.
This DNP project aligns with pediatric guidelines and Texas Department of State Heath
Service (Immunization Unit) by providing material to parents and families that will
support the best well-being and growth of children and adolescents.
Participants
I selected and designed an expert panel composed of community leaders and the
staff members who consented and agreed to participate in the present project (AppendixB). The participants were instructed on HPV vaccination importance regarding of
increase risk perceptions, to enhance HPV acceptance within communities. I
implemented bilingual educative activities and interventions after Institutional Review
Board (IRB) approval was secured. A collaborative leadership approach was used by
following ethical standards within practicum site. According to ANCC (2013)
Practitioners and organizational leaders reported that collaboration is a great strategy for
improving problem-solving and achieving expected goals.
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Procedures
I provided a consent form to all staff members (Appendix-B) and community
leaders participating in the project. Once they agreed, I created focus groups and HPV
immunization educational sessions. Data were collected onsite and kept confidentially.
The bilingual interventions were implemented with staff members at the clinic. The first
procedure includes significant findings from a focus group held with clinic staff members
regarding their perceptions of barriers to HPV vaccination. The second procedure focused
on providing information about the importance of HPV vaccine and its completion as per
immunization schedule (CDC, 2013) in three educational sessions provided to staff
members. Finally, a third procedure involved presenting results of the focus group and
educational sessions to clinic leadership and community leaders with the intention of
expanding HPV information into the community and institutionalizing the education in
the clinic via a revised policy. The feedback and interaction between a focus group and I
supported the project and helped to determine the most useful strategies to enhance HPV
acceptance and therefore increase immunization rate within targeted population.
Protections
I protected human subjects by securing IRB permissions obtained from
Committee and Ethics Commission as per Walden University DNP QI Capstone Rubric.
Results of the focus group discussion with staff members and community leaders were
safely kept confidential and anonymous as per ethical guidelines. The ethical
consideration from present DNP QI project was achieved by timely submission of
required paperwork to the IRB from Walden University before developing and
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implementing an educational tool and strategy to enhance HPV vaccination acceptance
within community targeted.
Analysis and Synthesis
Data from a focus group comprised of clinic staff members whose aim is to
enhance HPV vaccination acceptance were summarized. The data obtained were
collected through expressed thoughts, and comments from discussions between staff
members who participated in the focus groups. I summarized this information as
valuable evidence in support of the barriers identified through the literature. Bodenheimer
and Grumbach (2016) asserted that successful outcomes must be obtained from
stakeholders, policymakers, and community engagement to make a desired change.
Additional approaches to the subject of HPV included a literature review, national
guidelines reviews, current vaccine policy and protocol reviews, and gathering of input
and stakeholder satisfaction with DNP project focused on HPV immunization strategies
to enhance knowledge in patients and parents.
Most of the adolescents included in the project population were from a lowincome community, with Medicaid as the leading healthcare coverage funded by the
federal Vaccines for Children (VFC) program without any cost to their parents. This
federal program aligns with the Healthy People 2020 goals for reaching an 80% of
vaccination coverage despite socioeconomic level. The DHSS (2013) reported that it is
important to decrease miscommunication and reinforce education in a multicultural
society to increase HPV vaccination compliance. Kettner, Moroney, and Martin (2017)
asserted that educative forces promoted by organizations are great tools for positive
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input, and that miscommunication is a powerful obstacle to HPV vaccination acceptance.
An adequate educational intervention may increase knowledge on any given issue and
promote better engagement of population studied to solve it (Laurate Education, 2011).
Once the information was collected from staff members’ focus group, I analyzed it and
compared it to the literature review, incorporating this insight into the educational
program and patient education materials developed for the clinic. This information
allowed senior leaders of the clinic and front-line staff alike to direct their strategies to
improve educational goals and enhance educational level, and therefore increase HPV
acceptance and vaccination rate. According to Pitts and Adams, (2013) successful
educational strategies would enhance chance of attitudes and risk perceptions within
communities.
Finally, the results of the focus group, the educational sessions and materials were
presented to an expert panel made of community leaders and clinic leadership. The
expected outcomes of this final phase of the project included the following: (a) a finalized
policy for the clinic formalizing the educational approach and (b) a brainstorming
discussion with community leaders as to how they can support an educational process in
the community to further project goals and increase acceptance to HPV vaccination.
Summary
Multiple factors may decrease HPV vaccination intake within the targeted
population at Southwest area of Houston. Parental hesitancy, language barriers, a lack of
healthcare coverage, and poor risk perception of HPV infection are the most common
challenges to overcome when trying to facilitate completion of the HPV vaccine as
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recommended. Data collection for the DNP project was performed by compiling focus
group feedback and responses from the staff members on the usefulness of the
educational package. The project provided educational tools and materials that will
enhance knowledge of HPV prevention among adolescents and young adults. The next
two sections include descriptions of the completed project with the primary purpose of
discussing findings and providing recommendations that may engage stakeholders,
representatives, and legislators to solve this issue that affects a vulnerable population.
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Section 4: Findings and Recommendations
Introduction
The purpose of this QI scholarly project was to develop an educational
intervention for adolescents and parents regarding the importance of HPV vaccination.
The educational intervention was supported by a focus group process to discern
prominent barriers to HPV vaccination in the clinic patient population. Finally, results of
the focus group and educational sessions were presented to an expert panel consisting of
community leaders and clinic senior leader for validation of the need to continue the
project into the future.
Educational Intervention and Focus Group Results
I designed an educational intervention in Spanish and English for implementation
among adolescents and their parents, which was based on the literature review
summarized in Section 2 and on the results of the focus group held with clinic staff
members, to identify nature of parental resistance and to incorporate this insight into the
educational approach. This intervention is designed to increase awareness of HPV
vaccination at the clinic site, obtain an informed consent regarding the acceptance or
declination of the three dosages of HPV vaccine, engage to complete the three series as
recommended by CDC and further discussion of HPV importance with providers and
nurses. Mayne et al. (2012) described the importance of providing accurate information
regarding HPV vaccination, assure population will understand and reinforce information
given. Using patient education materials provided by the CDC (2017), I developed a fact
sheet written at a sixth-grade reading level, accompanied by a powerpoint that helped
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clinic staff members to understand the important concepts needed in order to influence
parental hesitancy and misconception regarding HPV vaccination (see Appendices C and
D). The purpose and the principal objective of this proposed QI project were to develop
an educational intervention to increase the HPV vaccination rate at an urban clinic in
Texas. The resources utilized included a fact sheet, a visual tool (provided both in
Spanish and in English) and a Powerpoint slide deck (see Appendix C, D, and E) related
to HPV vaccination.
Key findings and results of the focus group revealed two important
misconceptions held by parents of adolescents served in the clinic. The first was the
notion held by parents that one dose of vaccine was adequate to prevent their adolescents
from contracting the HPV virus. The second was more difficult to address, was a
complex set of concerns about the vaccine leading to the initiation of sexual activity and
(potential) promiscuity subsequently. Additional insight emerged as it was noted that
most parents do not consent for HPV vaccination due to a lack of knowledge about HPV
infection and poor risk perception of its consequences. The most common barrier is
parental hesitancy. Parental uncertainty may produce multiple results such as a poor HPV
coverage among teenagers (Bartlett & Peterson, 2012), loss of millions of dollars by
funding a vaccine with a little acceptance (Pitts & Adams, 2013), a higher risk of being
infected by HPV, and increased vulnerability of suffering anogenital and/or
oropharyngeal cancers (Hopkins & Wood, 2013).
During the discussion with the focus group, staff members reported that parents
have an attitude against HPV vaccine which were complicated by language barriers,
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miscommunication, and incorrect beliefs regarding vaccination. Tam et al. (2011)
asserted that poor communication between providers and nurses with adolescents and
their parents is the leading cause of low HPV vaccination intake. Rosenthal (2010)
described the importance of providers and nurses to recommend the HPV vaccination and
accurately explained the benefits as a healthcare promotion activity that will avoid HPV
infection and the consequences. A lack of Spanish educational materials and language
barriers were found to influence the HPV vaccination engagement among teenagers and
parents.
Additional crucial elements that formed the basis of instruction also included
vaccination availability, side effects, coverage, reimbursement and dosage required to
obtain a complete immunization against HPV. An alarm protocol was created so staff
may inform parents and adolescents about vaccination due dates and discuss additional
concerns as well. ImmTrac is software capable of tracking immunization dosage, and
other side effects or notes reported by the provider. ImmTrac consolidates and stores
immunization records from multiple sources electronically within the centralized system
(Department of Health & Human Services, 2013). The use of these alerts built into the
ImmTrac software was presented as part of the educational model with the staff. When
this is combined with the patient focused educational tools, taken together these are
powerful adjuncts that the clinic staff can use with parents to reinforce knowledge of
HPV vaccination’s benefits. Pitt and Adams (2013) proposed educational strategies and
tools accompanied by graphics that allows patients to understand and enhance
information given.

30
Southwest Metropolitan clinic staff members (n=15) who attended the educational
program and participated in the focus group included four medical assistants, three
registered nurses, five nurse practitioners, one DNP, and two physicians (Family Practice
MDs). The educational intervention was conducted in 30-45 minute sessions. A
PowerPoint slide deck, a bilingual fact sheet (in Spanish and English), and visual tools
(see Appendices C, D and E) were used to enhance HPV education level within staff
members at the clinic, and through them, the population targeted. The educational
intervention and tools provided should increase acceptance of HPV vaccine, engage
parents and teenagers to complete the three doses as recommended, and improve
education regarding this vaccination with the primary purpose to enhance the HPV
vaccine rate within targeted population.
Clinic Senior Leader and Community Leaders
The final phase of the DNP project was held in a meeting with the leadership
expert panel made up of a senior clinic leader and five community leaders: from YMCA
(Refugee Organization), United Healthcare, Molina Insurance company, Texas Children
Hospital and Houston Foodbank. The purpose of this meeting was to present the expert
panel with the results of the focus group and the educational sessions with clinic staff and
to brainstorm ways to further disseminate the educational materials and program
throughout the community. During this phase, the expert panel were asked to sign
consent for their participation in the project (Appendix B) and the objectives and goals of
the project were reviewed.
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The leadership expert panel reported that most affected ethnic group is the
Hispanic, mostly because language barriers and many families are forced to return to
their native countries; therefore, it is difficult for them to complete the three-dose series
as required. Finally, these experts agreed that common reasons for HPV lack of
acceptance included poor risk perception about HPV consequences and erroneous
advertisement in certain websites which prevents parents’ consent to HPV vaccination for
their children. These experts also noted that because it is not a mandatory vaccine, many
parents are not encouraged to consent to HPV immunization for their sons and daughters.
The expert panel concurred with the focus group and clinic staff members that
most parents do not consent for HPV vaccination due to a lack of knowledge about HPV
infection and poor risk perception of its consequences. The most common barrier is
parental hesitancy. Parental uncertainty may produce results such as a poor HPV
coverage among adolescents (Bartlett & Peterson, 2012), loss of millions of dollars by
funding a vaccine with a little acceptance (Pitts & Adams, 2013), a higher risk of being
infected by HPV, and increased vulnerability of suffering anogenital and/or
oropharyngeal cancers (Hopkins & Wood, 2013).
After discussing the main barriers that interfere with accepting HPV vaccination
within the clinic population, the expert panel was presented with tools to implement in
the community. These included advantages of HPV vaccination due its further benefits to
prevent oral and rectal cancer, and included teaching regarding appropriate use of
condom to prevent additional STDs such as HIV, herpes genital, gonorrhea, syphilis, and
chlamydia. During this session, the same materials as used in the clinic were presented:
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bilingual fact sheet, visual tool and Powerpoint slide deck that will enhance knowledge
and awareness of HPV vaccine benefits, but also provide accurate information about
healthcare coverage, vaccine availability and additional centers that may provide this
immunization free of cost. The primary goal of this session was to provide tools to
overcome described barriers and educate the population in Spanish and English regarding
HPV infection consequences.
Members of the expert panel discussed presented tools and strategies aimed at
increasing HPV vaccination acceptance within the community. All participants reported
that most Hispanic populations were interested in learning more about HPV vaccination
in their native language (Spanish), and were encouraged to visit a provider to obtain more
information about HPV coverage, and its benefits for adolescents. Another strategy
discussed was implementing wellness health fair at schools and colleges which would be
a perfect fit to promote HPV vaccination and spread its benefits among teenagers.
As an extension of the expert panel session, I also met with Texas Immunization
Department and Texas Childrens Hospital nursing directors to discuss outcomes on HPV
vaccination in Texas and nationwide. All agreed about the importance of providing a
higher level of disease prevention and HPV vaccination promotion in different languages
other than English as particular groups of the population will better understand
vaccination benefits and its importance in children and adolescents. These experts also
agreed that the materials developed in this DNP project (HPV vaccination fact sheet in
English and Spanish and the Powerpoint slide deck) have great potential for broader
application beyond the clinic site.
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The expert panel advocated for participation in a wellness clinic fair at two
apartment complexes in the Southwest Houston metropolitan area and sponsored by
Texas Children Hospital, United Healthcare, and Houston Foodbank. A detailed
explanation of the bilingual fact sheets regarding HPV vaccination intended for
adolescents who will return to high school after summer vacations was provided. During
these health clinics, which were staffed by clinic personnel, it was demonstrated that
most parents would bring adolescents to the clinic and give consent for HPV vaccination
after a clear understanding of its benefits. During the last week of project, clinic staff
reported a total of 14 parents who brought their adolescents to the clinic for physical
exam and HPV administration (initial and subsequent dosage). This represents an
increase of 37.8 % of parents providing consent to their adolescents compared to a
similar period in 2016. Though these results are preliminary as they represent a small
sample and brief period of time, they are indeed positive outcomes.
Finally, the Southwest Metropolitan Clinic’s director and administrator decided to
implement the proposed bilingual fact sheet and Powerpoint slides (the tools developed
for the project) for use with parents and adolescents, and protocol alert system (for staff
members to use with ImmTrac), as part of an internal clinic policy, (Appendix E) meant
to keep increasing HPV vaccination rate and parental acceptance. Finally, these tools
help to ensure accurate documentation of HPV immunization and properly tracking to the
adolescents that are due for first or subsequent HPV dosage.
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Recommendations
Upon DNP QI Project implementation and following its’ finding and results
during intervention, I recommend expanding educational strategies to other clinics;
regional, state, and nationwide organizations to increase awareness of such healthcare
gap, to engage multiple stakeholders, policymakers, federal, and profit organizations in
the hopes of achieving similar results. I also recommend increasing school vaccinations
and wellness health fairs within the communities to provide more education regarding
HPV vaccine, to potentially improve vaccination rate regionally and nationally.
Strengths and Limitations of the Project
One of the strengths of this DNP QI project is the development of a collaborative
team, providing Spanish and English education related HPV vaccination within a
multicultural population. The success of such implementation is supported by a more
educative and effective communication between providers and parents and their
adolescents. Seto, Marra, Raymakers, and Marra (2012) determined a 32% of increased
vaccination rate among Hispanics after native language intervention was provided.
Stokley (2013) developed educational strategies accompanied by graphic tools which
allowed the population to gain a better understanding of information given. Another
strength is the use of alerts developed for software such as ImmTrac, which will improve
tracking patients who received the HPV vaccination, adolescents’ due for the second or
third dosage, and monitoring side effects of such immunization all over Texas. Another
strength of the project relates to policymakers’ involvement, which may be influenced by
this DNP QI project. I have been working closely with AANP TX State Representatives
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as an active NP member leader from my community aimed at increasing awareness of
HPV vaccination.
The main limitation for this DNP QI project is that providers administer the HPV
vaccination as part of a wellness visit, and therefore some educational instructions may
be missing during the consultation and further follow up of teenagers due a busy
workflow and lack of time. According to Tam et al. (2012), educative tools required an
organized and strong collaborative team capable to fit patient’s schedule into required
time frame that allows providers and nurses to reinforce education given. McCase (2014)
indicated that school vaccination programs are the best tools to increase immunization
rate within a population targeted. Despite these limitations, the tools developed for this
DNP project represent an important step in creating higher rates of HPV vaccination
among this vulnerable population: this is a significantly positive social change.
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Section 5: Dissemination Plan
Online resources and further publication of existing educational tools developed
for this DNP project will be the most successful form of dissemination. The publication
throughout reputable websites would increase awareness of current health issue (lack of
HPV vaccination acceptance). The Journal of Public Health and CDC quarterly report are
excellent sites to publish the results of this DNP QI project and its’ outcomes. By
publishing this manuscript, I will provide additional tools and resources to engage
policymakers, stakeholders, and legislators on this disease prevention issue that identifies
adolescents as a vulnerable population. Per Stokley (2013), this phase of DNP project
will acknowledge further policies and guidelines related to disease prevention and
healthcare promotion activities aimed at providing a higher quality of care within
population targeted.
Spanish and English graphic booklets and posters constitute additional tools that
emerge from this DNP QI project, which can be disseminated broadly through local
communities. This method of dissemination is the most common strategy to spread
results, discussion, comparison with another sources and recommendations according to
ANCC. This presentation tool and further dissemination strategies will also provide a
trampoline to excel and improve additional educative feedback between author and
professionals nationwide. Perkins and Clark (2012) both asserted the importance of
spreading doctorate objectives and outcomes with the main purpose of evaluating and
consolidating current issues, and properly approaching additional solution.
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Educational resources, graphic information, and clear language available on
reputable websites, will facilitate provider-patient interaction and communication.
Moreover, I will have the opportunity to link product into others healthcare network that
will be available to clinics, hospitals, schools and community centers which allow further
guideline review and increase education level among parents and adolescents, and
therefore enhance HPV vaccination acceptance within the community. Other scholars. By
networking and disseminating DNP outcomes and recommendations, additional research
on this topic can be generated aim to obtaining a higher quality of care for patients,
families, and communities (Scott, 2016).
The process leading to the presentation of the results and dissemination of
educative intervention will be divided into four parts: abstract development; presentation
of graphic material, educative intervention; and formal presentation and the defense of
the results obtained throughout oral presentation.
Conclusion
I developed an intervention in a fact sheet written in a sixth-grade reading level,
accompanied by a PowerPoint slide deck that would help to facilitate learning among
parents and adolescents. During the intervention with an expert leadership panel
composed of staff members and community leaders, it was reported by most of them that
parents have an attitude against HPV vaccine which emerges through language barriers,
miscommunication, and the erroneous beliefs regarding vaccination. By publishing this
manuscript to the Journal of Public Health for publication, I will provide additional tools
and resources to engage policymakers, stakeholders, and legislators on this disease
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prevention issue that place adolescents as vulnerable population, and propose further
immunization guideline review and educative tools.
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Appendix B: Consent Form

Dear participant: ___________________________
As part of DNP QI project, you are invited to participate in the present project
“Educational Intervention for Engaging Adolescents and Their Parents in HPV
Vaccination”. The purpose of this study is to enhance educational level regarding HPV
immunization among parents and adolescents, and therefore to increase vaccination
acceptance. You were chosen as a possible participant in this project as a reliable source
of information, and because of your ability to engage the community regarding HPV
vaccination. Your signature below indicates your consent to participate in this project.
Data will be collected onsite and kept confidentially and all data will be anonymous.
Please feel free to ask questions regarding this project.
Thank you for your cooperation
Once signed, present consent also indicates that I am at least 18 years of age and
agree to participate in present study.

I agree to participate

Signature ______________________________
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Appendix C: HIV Fact Sheets
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HPV Facts Sheets
What is genital HPV infection?
Genital human papillomavirus (also called HPV) is the most common sexually
transmitted infection (STI). There are more than 40 types of HPV that can infect the
genital areas of males and females. These HPV types can also infect the mouth and
throat.
HPV can cause serious health problems, including genital warts and certain cancers.
There is no certain way to tell who will develop health problems from HPV and who will
not. In most cases HPV goes away by itself before it causes any health problems, and
most people who become infected with HPV do not even know they have it.
HPV is not the same as herpes or HIV (the virus that causes AIDS). Both viruses can be
passed on during sex, but they have different symptoms and cause different health
problems.
Who is at risk for HPV?
Anyone who is having (or has ever had) sex can get HPV. HPV is so common that nearly
all sexually-active men and women get it at some point in their lives. This is true even for
people who only have sex with one person in their lifetime.
How do people get HPV?
HPV is passed on through genital contact, most often during vaginal and anal sex. HPV
may also be passed on during oral sex and genital-to-genital contact. HPV can be passed
on between straight and same-sex partners—even when the infected person has no signs
or symptoms.
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Most infected persons do not realize they are infected, or that they are passing HPV on to
a sex partner. A person can still have HPV, even if years have passed since he or she has
had sexual contact with an infected person. It is also possible to get more than one type of
HPV.
In rare circumstances, a pregnant woman with genital HPV can pass the HPV on to her
baby during delivery.
What are the potential health problems caused by HPV?
Most people with HPV never develop symptoms or health problems. Most HPV
infections (90%) go away by themselves within two years. But, sometimes, HPV
infections will persist and can cause a variety of serious health problems. Health
problems that can be caused by HPV include
Genital warts (warts on the genital areas);
Recurrent respiratory papillomatosis (RRP), a rare condition in which warts grow
in the throat;
Cervical cancer, cancer on a woman’s cervix; and
Other, less common, but serious cancers, including genital cancers (cancer of the
vulva, vagina, penis, or anus), and a type of head and neck cancer called oropharyngeal
cancer (cancer in the back of throat, including the base of the tongue and tonsils).
All cases of genital warts and RRP, and nearly all cases of cervical cancer, are caused by
HPV. A subset of cancers of the vagina, vulva, anus, penis, and oropharynx, are caused
by HPV.
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The types of HPV that can cause genital warts are not the same as the types of HPV that
can cause cancers.
Signs and symptoms of health problems caused by HPV:
Genital warts usually appear as a small bump or group of bumps in the genital area. They
can be small or large, raised or flat, or shaped like a cauliflower. Healthcare providers can
usually diagnose warts by looking at the genital area. Warts can appear within weeks or
months after sexual contact with an infected partner—even if the infected partner has no
signs of genital warts. If left untreated, genital warts might go away, remain unchanged,
or increase in size or number. The types of HPV that can cause genital warts are not the
same as the types of HPV that can cause cancers.
Cervical cancer usually does not cause symptoms until it is quite advanced. For this
reason, it is important for women to get regular screening for cervical cancer. Screening
tests can find early signs of disease so that problems can be treated early, before they ever
turn into cancer.
Other cancers caused by HPV might not have signs or symptoms until they are advanced
and hard to treat. Other HPVassociated cancers include some cancers of the vulva,
vagina, penis, anus, and oropharynx.
RRP is a condition in which warts grow in the throat. RRP can occur in children
(juvenile-onset) and adults (adult-onset). These growths can sometimes block the airway,
causing a hoarse voice or trouble breathing. How does HPV lead to health problems?
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In most cases the virus goes away and it does not lead to any health problems. However,
when the virus persists, or does not go away, HPV can cause normal cells to become
abnormal and, most of the time you cannot see or feel these cell changes.
Warts can appear within months after getting HPV.
Cancer often takes years—even decades—to develop after a person gets HPV.
There is no certain way to know which people infected with HPV will go on to develop
cancer or other health problems. However, persons with weak immune systems
(including persons with HIV) may be less able to fight off HPV and more likely to
develop health problems from it.
How common are HPV and health problems caused by HPV?
HPV (the virus):
Approximately 79 million Americans are currently infected with HPV. About 14 million
people become newly infected each year. HPV is so common that nearly all sexuallyactive men and women will get at least one type of HPV at some point in their lives.
Genital warts: About 360,000 persons in the U.S. get genital warts each year.
Cervical cancer: About 12,000 women in the U.S. get cervical cancer each year.
Other cancers:
Other cancers can be caused by HPV, including some vaginal, vulvar, penile, anal, and
oropharyngeal cancers: Each year in the U.S., HPV is thought to cause an estimated –
2,100 vulvar cancers, – 500 vaginal cancers, – 600 penile cancers, – 2,800 anal cancers in
women,
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*Note: Other factors, notably tobacco and alcohol use, may also play a role with HPV to
cause these cancers. About 21,000 of these cancers are potentially preventable by HPV
vaccines.
1,500 anal cancers in men,
1,700 oropharyngeal cancers in women* and
6,700 oropharyngeal cancers in men
Recurrent respiratory papillomatosis (RRP) is very rare. It is estimated that about 820
children get juvenile-onset RRP every year in the U.S.
What is the difference between HPV and HIV?
HPV is a different virus than HIV, and causes different health problems. HPV does not
live in the blood cells, but rather lives on the skin. Also, whereas HIV can lead to AIDS,
genital HPV can lead to genital warts and certain types of cancer. However, persons with
HIV are more likely to get HPV and to develop health problems from HPV. This is
especially true for anal cancer.
Does HPV affect a pregnant woman and her baby?
Women who are pregnant can get infected with HPV. Usually these infections do not
cause any problems. But sometimes

HPV leads to genital warts, which can grow

during pregnancy. Women with genital warts during the late stages of pregnancy are
more likely to have children with warts in the throat, a condition called recurrent
respiratory papillomatosis; however, this is a very rare condition.
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Pregnant women can develop cervical cell changes due to HPV. These changes can be
detected through routine cervical cancer screening. Women should get routine cervical
cancer screening, even during pregnancy.
Is there a test for HPV?
HPV tests are available to help screen women aged 30 years and older for cervical
cancer. These HPV tests are not recommended to screen men, adolescents, or women
under the age of 30 years. There is no general HPV test for men or women to check one’s
overall “HPV status.” Also, there is not an approved HPV test to find HPV in the mouth
or throat.
How can HPV be prevented?
There are several ways that people can lower their chances of getting HPV: HPV
vaccines are recommended for 11- or 12-year-old boys and girls. HPV vaccines are safe
and effective, and can protect males and females against some of the most common types
of HPV that can lead to disease and cancer. HPV vaccines are given in three shots over
six months; it is important to get all three doses to get the best protection. Boys and girls
at ages 11 or 12 are most likely to have the best protection provided by HPV vaccines,
and their immune response to vaccine is better than older women and men.
Girls and women: Two vaccines (Cervarix and Gardasil) are available to protect females
against the types of HPV that cause most cervical cancers. One of these vaccines
(Gardasil) also protects against most genital warts, and has been shown to protect against
anal, vaginal, and vulvar cancers. Either vaccine is recommended for 11- and 12-yearold
girls, and for females 13 through 26 years of age who did not get any or all of the shots
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when they were younger. These vaccines can also be given to girls beginning at 9 years
of age.
Boys and men: One vaccine (Gardasil) is available to protect males against most genital
warts and anal cancers. Gardasil is recommended for 11- and 12-year-old boys, and for
males 13 through 21 years of age who did not get any or all of the shots when they were
younger. Gay, bisexual, and other men who have sex with men should receive the
vaccine through age 26 years. Males 22–26 years of age may also get the vaccine.
For those who choose to be sexually active, condoms may lower the risk of HPV.
Condoms may also lower the risk of developing HPV-related diseases, such as genital
warts and cervical cancer. To be most effective, condoms should be used with every sex
act, from start to finish. HPV can infect areas that are not covered by a condom – so
condoms may not fully protect against HPV.
People can also lower their chances of getting HPV by being in a faithful relationship
with one partner; limiting their number of sex partners; and choosing a partner who has
had no or few prior sex partners. But even people with only one lifetime sex partner can
get HPV, and it may not be possible to determine if a person who has been sexually
active in the past is currently infected. Because HPV is so common, and almost every
sexually-active person will get HPV at some time in their lives, it is important to protect
against the possible health effects of HPV.
Can people prevent health problems caused by HPV?
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Yes, there are different prevention strategies for different health problems caused by
HPV. HPV vaccines can prevent many diseases and cancers caused by HPV. In addition
to vaccination, there are other ways to lower the risk of health problems caused by HPV.
A person can lower their risk of cervical cancer by getting routine screening if they are a
woman aged 21–65 years (and following up on any abnormal results);
Oropharyngeal cancers by avoiding tobacco and limiting alcohol intake; and Genital
warts by using condoms all the time and the right way.
Is there a treatment for HPV or health problems caused by HPV?
There is no treatment for the virus itself, but there are treatments for the health problems
that HPV can cause:
Genital warts can be removed with treatments applied by the provider or the person
himself/herself. No one treatment is better than another. Some people choose not to treat
warts, but to see if they disappear on their own. If left untreated, genital warts may go
away, stay the same, or grow in size or number.
Cervical cancer is most treatable when it is diagnosed and treated early. Women who get
routine Pap tests and follow up as needed can identify problems before cancer develops.
Prevention is always better than treatment. For more information visit www.cancer.org.
Other HPV-related cancers are also more treatable when diagnosed and treated early. For
more information visit www.cancer.org.
Recurrent respiratory papillomatosis (RRP) can be treated with surgery or
medicines. Curing RRP can sometimes require many treatments or surgeries over a
period of years.
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Where can I get more information?
STD information http://www.cdc.gov/std/
HPV Information http://www.cdc.gov/hpv/
HPV Vaccination http://www.cdc.gov/vaccines/vpd-vac/hpv/
Cancer Information http://www.cdc.gov/cancer/
Cervical Cancer Screening http://www.cdc.gov/cancer/cervical/basic_ info/screening.htm
CDC’s National Breast and Cervical Cancer Early Detection Program
http://www.cdc.gov/cancer/nbccedp/
CDC-INFO Contact Center 1-800-CDC-INFO (1-800-232-4636) TTY: (888) 232-6348
CDC National Prevention Information Network (NPIN)
http://www.cdcnpin.org/scripts/index.asp P.O. Box 6003 Rockville, MD 208496003 1-800-458-5231 1-888-282-7681 Fax 1-800-243-7012 TTY E-mail:
info@cdcnpin.org
National HPV and Cervical Cancer Prevention Resource Center American Sexual
Health Association (ASHA) http://www.ashastd.org/std-sti/hpv.html P. O. Box 13827
Research Triangle Park, NC 27709-3827 1-800-783-9877
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Appendix D: HPV Powerpoint
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Appendix E: Southwest Clinic HPV Vaccination Policy
The Advisory Committee on Immunization Practices (ACIP), Texas
Immunization Department and Southwest Metropolitan Clinic implement to administer
the vaccine to girls and boys between 11 and 12 years of age, but as early as 10 years old
before they become sexually active. The available HPV vaccine will be quadrivalent
human papillomavirus (HPV) vaccine (HPV4; Gardasil, Merck & Co. Inc.) and it will be
covered by Medicaid, CHIP and United Community Plan. By following the article at
H.B. 1379, adolescents and their parents will receive educational materials in both
English and Spanish. All employees at Southwest Metropolitan Clinic are required to
track and document Human Papilloma Virus administration within Meditrek. This HPV
Vaccination Policy was discussed and approved by Dr. William Cohen (Family Practice,
M.D-Medical Director) and Dr. Stella Eke (CEO and owner of family and pediatric
clinic).

